Related Experiment Videos
A solid phase assay for the protease of human immunodeficiency virus
E M Wondrak1, T D Copeland, J M Louis
1Laboratory of Molecular Virology and Carcinogenesis, NCI-Frederick Cancer Research Facility, Maryland 21701.
Analytical Biochemistry
|July 1, 1990
Summary
A new solid phase assay was developed for human immunodeficiency virus (HIV) protease. This assay enables efficient monitoring of purification and rapid screening of potential HIV protease inhibitors.
Area of Science:
- Biochemistry
- Enzymology
- Virology
Background:
- Human immunodeficiency virus (HIV) protease is a critical enzyme for viral replication.
- Developing efficient assays for HIV protease is essential for drug discovery and understanding viral mechanisms.
Purpose of the Study:
- To devise a novel solid phase assay for human immunodeficiency virus (HIV) protease.
- To enable convenient monitoring of purification procedures for HIV protease.
- To facilitate rapid screening of potential inhibitors targeting HIV protease.
Main Methods:
- Development of a solid phase assay utilizing an immobilized substrate (Affi Gel 10-Gly-Gly-Gly-Gly-Val-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-[3H]Gly-OH).
- Hydrolysis of the Tyr-Pro bond in the substrate by HIV protease.
- Quantification of the released radiolabeled cleavage product (Pro-Ile-Val-Gln-[3H]Gly-OH) in the supernatant.
Main Results:
- The assay successfully employed an immobilized substrate for HIV protease activity detection.
- The optimal pH for the assay was determined to be 6.0.
- Maximal enzyme activity was observed at high ionic strength.
Conclusions:
- The developed solid phase assay provides a convenient method for monitoring HIV protease purification.
- This assay is suitable for the rapid screening of compounds that inhibit HIV protease activity.
- The findings contribute to the development of new therapeutic strategies against HIV.